MicroPort Orthopedics Announces Second Annual Global Medial-Pivot Symposium in Phoenix, Arizona from October 13-14

MicroPort Orthopedics, a global leader in orthopedic devices and technologies, today announces that registration is open for its second annual Global Medial-Pivot Symposium in Phoenix, Arizona from October 13-14, 2023. This event will highlight the growing popularity of medially stabilizing total knee arthroplasty designs with a robust program to celebrate the 25 years of clinical excellence of MicroPort Orthopedics’ Medial-Pivot Knee, its simple and reproducible surgical technique helping surgeons deliver better, more consistent outcomes for their patients.

The symposium is led by a committee of world-renowned orthopedic surgeons including:
  • Lowry Barnes, MD, Professor and Chair of the Department of Orthopaedic Surgery at University of Arkansas

  • David Backstein, MD, MEd, FRSC, Associate Professor at the University of Toronto, the head of Granovsky Gluskin Division of Orthopaedics at Mount Sinai Hospital, and the medical lead and chair at the Mount Sinai Centre for Musculoskeletal Disease

  • Pier Francesco Indelli, MD, PhD, Clinical Associate Professor (affiliated), Orthopedic Surgery Stanford University School of Medicine

  • Philippe Van Overschelde, MD, MScs, Hip and Knee Unit of the AZ Maria-Middelares Clinic in Gent, Belgium

  • Alexander Sah, MD, Co-Director for the Institute for Joint Restoration and Research and the Director of Outpatient Joint Replacement Program at Washington Hospital

  • Ran Schwarzkopf, MD, Professor of Orthopaedic Surgery NYU Langone Orthopedic Hospital, Associate Chief Division of Adult Reconstruction Surgery, Director Research Center Division of Adult Reconstruction Surgery, Associate Program Director Orthopaedic Surgery Residency Department of Orthopaedic Surgery-NYU Hospital for Joint Diseases/NYU Langon Health

Attendees can expect an in-depth review from invited keynote speakers of Medial-Pivot design principles and scientific evidence, and how alignment strategies and advanced digital technologies can maximize the clinical benefits of medial-pivot design. Sessions will examine current trends in TKA, the evolution of TKA implant designs, and how this evolution affects knee joint kinematics. The program will also cover personalized solutions for the complete episode of care by coupling with improved patient pathways.
“Building upon the inaugural event of last year, the Global Medial-Pivot Symposium will be an opportunity for top Orthopedic surgeons to further explore the medial-pivot knee design.” said symposium chair Lowry Barnes, MD. “We share a common goal to increase long-term survivorship, accelerate recovery, and improve our patient’s outcomes. This symposium will serve as a platform to discuss the role of medially stabilizing TKA designs in achieving this goal and more.”
“This will be the 25th anniversary of the MicroPort Orthopedics Medial-Pivot knee implant,” said Barnes, “I look forward to encouraging interest and stimulating new ideas for the future of knee replacement.”
MicroPort Orthopedics offers various products and techniques to help patients receiving total hip and knee replacements achieve Full Function, FasterⓇ. For more information or to register, visit https://go.microportortho.com/2nd-medial-pivot-symposium.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”